Other drugs and convalescent plasma Source: Virtual Congress 2020 – Management Year: 2020
Serum acute phase reactants in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
Management of COVID-19: Other drugs and convalescent plasma Source: ERS Course 2021 - COVID-19: State of the art Year: 2021
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma Source: Eur Respir J, 59 (2) 2101724; 10.1183/13993003.01724-2021 Year: 2022
Effect of corticosteroid therapy upon serum magnesium level in chronic asthmatic children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010
Short versus prolonged low dose steroid therapy early in the course of acute lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 263s Year: 2004
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003
Plasma concentrations of four corticosteroids following inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 215s Year: 2005
Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002
Systemic effects of nebulized salbutamol on serum potassium, glucose and CPK-MB levels in children with acute reversible reactive airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007
Plasma levels of sP- and sL-selectin in early and late asthmatic responders after allergen challenge Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003
High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003
Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018
The Importance of the local expression of acute phase reactants in the COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010